Tuebingen

Latest articles

28d
News-Medical-Net
Research finding could pave way for novel compounds to tackle bacterial resistanceby Monash Biomedicine Discovery Institute's (BDI) Associate Professor Max Cryle
News-Medical-Net / Posted 28 days ago
by Monash Biomedicine Discovery Institute's (BDI) Associate Professor Max Cryle, and Dr Evi Stegmann from the University of Tuebingen, Germany, investigated what are called glycopeptide antibiotics including vancomycin, a drug used as a last resort... Read more

In this news